Brown Financial Advisors Boosts Stock Position in The Cigna Group (NYSE:CI)

Brown Financial Advisors raised its holdings in The Cigna Group (NYSE:CI) by 16.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,435 shares of the health services provider’s stock after buying an additional 199 shares during the period. Brown Financial Advisors’ holdings in The Cigna Group were worth $396,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of CI. Prospera Private Wealth LLC acquired a new stake in shares of The Cigna Group during the 3rd quarter worth about $37,000. Collier Financial purchased a new position in The Cigna Group in the fourth quarter valued at approximately $32,000. ORG Wealth Partners LLC acquired a new stake in The Cigna Group during the fourth quarter worth approximately $34,000. Harbor Capital Advisors Inc. purchased a new stake in shares of The Cigna Group during the 3rd quarter worth approximately $45,000. Finally, Compagnie Lombard Odier SCmA acquired a new position in shares of The Cigna Group in the 4th quarter valued at $37,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

The Cigna Group Trading Up 0.3 %

Shares of The Cigna Group stock opened at $300.80 on Tuesday. The firm has a market cap of $83.67 billion, a price-to-earnings ratio of 24.58, a price-to-earnings-growth ratio of 0.98 and a beta of 0.54. The Cigna Group has a 52-week low of $262.03 and a 52-week high of $370.83. The company’s 50-day simple moving average is $286.90 and its 200-day simple moving average is $319.23. The company has a quick ratio of 0.72, a current ratio of 0.66 and a debt-to-equity ratio of 0.70.

The Cigna Group (NYSE:CI) last released its earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same period last year, the firm posted $6.79 EPS. As a group, equities research analysts anticipate that The Cigna Group will post 29.77 earnings per share for the current year.

The Cigna Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 20th. Shareholders of record on Wednesday, March 5th will be given a $1.51 dividend. This is a boost from The Cigna Group’s previous quarterly dividend of $1.40. The ex-dividend date is Wednesday, March 5th. This represents a $6.04 annualized dividend and a yield of 2.01%. The Cigna Group’s dividend payout ratio is presently 49.35%.

Analysts Set New Price Targets

Several equities research analysts recently commented on the stock. Deutsche Bank Aktiengesellschaft cut their price target on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a research note on Monday, November 4th. Piper Sandler reiterated an “overweight” rating and set a $348.00 target price (down previously from $394.00) on shares of The Cigna Group in a research report on Monday, February 3rd. Royal Bank of Canada set a $355.00 target price on The Cigna Group in a report on Friday, January 31st. Truist Financial dropped their price target on The Cigna Group from $390.00 to $375.00 and set a “buy” rating on the stock in a research note on Tuesday, February 4th. Finally, Sanford C. Bernstein cut The Cigna Group from an “outperform” rating to a “market perform” rating and set a $323.00 price objective for the company. in a research note on Thursday, February 6th. Two equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Buy” and an average target price of $372.31.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.